O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-15.33%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$9.89B
AUM Growth
+$9.89B
(-16%)
Cap. Flow
+$87.5M
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
40.11%
Holding
146
New
15
Increased
26
Reduced
29
Closed
10
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$107M |
| 2 |
Eli Lilly
LLY
|
$106M |
| 3 |
WMGI
Wright Medical Group Inc
WMGI
|
$98M |
| 4 |
HCA Healthcare
HCA
|
$63.5M |
| 5 |
Dynavax Technologies
DVAX
|
$60.7M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$161M |
| 2 |
SHPG
Shire pic
SHPG
|
$132M |
| 3 |
TRNX
TORNIER N V SHARES (NLD)
TRNX
|
$120M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$119M |
| 5 |
Gilead Sciences
GILD
|
$69.8M |
Sector Composition
| 1 | Healthcare | 92.21% |
| 2 | Financials | 0.24% |
| 3 | Technology | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bristol-Myers Squibb
BMY
$96B
| $513M | 5.18% | 8,668,100 +917,000 | +12% | +$54.3M |
|
|
2
HCA Healthcare
HCA
$94.5B
| $452M | 4.56% | 5,837,900 +820,500 | +16% | +$63.5M |
|
3
Amgen
AMGN
$155B
| $417M | 4.21% | 3,013,000 +132,000 | +5% | +$18.3M |
|
4
Boston Scientific
BSX
$156B
| $394M | 3.98% | 24,007,200 +2,327,200 | +11% | +$38.2M |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $392M | 3.96% | 1,443,315 -68,000 | -4% | -$18.5M |
|
|
CELG
6
DELISTED
Celgene Corp
CELG
| $389M | 3.92% | 3,593,000 -233,000 | -6% | -$25.2M |
|
7
Biogen
BIIB
$19.4B
| $382M | 3.85% | 1,307,400 +28,500 | +2% | +$8.32M |
|
8
AbbVie
ABBV
$372B
| $378M | 3.81% | 6,943,200 +278,200 | +4% | +$15.1M |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $348M | 3.52% | 2,226,600 +182,200 | +9% | +$28.5M |
|
10
Incyte
INCY
$16.5B
| $302M | 3.05% | 2,740,978 +426,478 | +18% | +$47.1M |
|
|
IPXL
11
DELISTED
Impax Laboratories, Inc.
IPXL
| $235M | 2.37% | 6,664,100 -75,100 | -1% | -$2.64M |
|
12
Regeneron Pharmaceuticals
REGN
$61.5B
| $227M | 2.29% | 487,700 +25,900 | +6% | +$12M |
|
13
Molina Healthcare
MOH
$9.8B
| $223M | 2.25% | 3,236,300 -251,600 | -7% | -$17.3M |
|
|
14
Gilead Sciences
GILD
$140B
| $214M | 2.17% | 2,184,400 -711,000 | -25% | -$69.8M |
|
|
HNT
15
DELISTED
HEALTH NET INC
HNT
| $205M | 2.07% | 3,397,800 -304,400 | -8% | -$18.3M |
|
16
Illumina
ILMN
$15.8B
| $202M | 2.04% | 1,151,000 | – | – |
|
17
Cooper Companies
COO
$13.4B
| $194M | 1.96% | 1,301,400 | – | – |
|
|
ICPT
18
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $186M | 1.88% | 1,120,000 | – | – |
|
19
Thermo Fisher Scientific
TMO
$186B
| $167M | 1.68% | 1,364,000 -38,000 | -3% | -$4.65M |
|
|
WMGI
20
DELISTED
Wright Medical Group Inc
WMGI
| $166M | 1.68% | 8,142,000 +4,805,000 | +144% | +$98M |
|
21
Neurocrine Biosciences
NBIX
$13.8B
| $152M | 1.53% | 3,816,050 -1,278,450 | -25% | -$50.9M |
|
|
RLYP
22
DELISTED
RELYPSA INC COM
RLYP
| $137M | 1.38% | 7,400,000 | – | – |
|
|
SHPG
23
DELISTED
Shire pic
SHPG
| $136M | 1.38% | 664,400 -641,600 | -49% | -$132M |
|
24
McKesson
MCK
$85.4B
| $130M | 1.31% | 700,000 -18,000 | -3% | -$3.33M |
|
|
25
Teva Pharmaceuticals
TEVA
$21.1B
| $124M | 1.25% | 2,199,000 +1,892,000 | +616% | +$107M |
|